Shenzhen Neptunus Interlong Bio-technique Company Limited
Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Stock Forecast & Price Predictions
Get the latest Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.
Model Information
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMonthly Forecast
Quarterly Forecast
Yearly Forecast
3 Years Forecast
5 Years Forecast
7 Years Forecast
Shenzhen Neptunus Interlong Bio-technique Company Limited Stock Forecast Summary
Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) stock is currently priced at $0.12. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $0.25.
In the long term, 8329.HK shows a bullish trend. The 2027 forecast points to $0.17 (36.30% change), while the 2031 forecast suggests $0.19 (57.13% change). Looking 7 years ahead, projections estimate the stock could trade near $0.21, a 68.59% change from today’s price.
Bullish
Bullish
Bullish
This mix indicates that Shenzhen Neptunus Interlong Bio-technique Company Limited stock is expected to rise steadily over the coming years.
Investment Calculator
Estimate your potential returns on 8329.HK based on our AI price forecasts. Enter your investment amount and select a target date.
Based on your investment of HK$1,000.00 in Shenzhen Neptunus Interlong Bio-technique Company Limited and holding until April 5th, 2027, you could make a potential +HK$362.95 profit, reflecting a +36.3% ROI over the next 365 days.
$Shares Bought
8,130.0813
@ HK$0.12/share
~Forecast Price
HK$0.17
1-year AI forecast
$Est. Portfolio Value
HK$1,362.95
+HK$362.95 profit
%ROI
+36.3%
return on investment
Shenzhen Neptunus Interlong Bio-technique Company Limited yearly Price Forecast Chart
Explore the yearly forecast chart for 8329.HK, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Shenzhen Neptunus Interlong Bio-technique Company Limited over different timeframes.
No forecast data available
No prediction data found for this time period.
Forecasting data is not available for 8329.HKForecasting details for 8329.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Shenzhen Neptunus Interlong Bio-technique Company Limited Stock Forecast 2026
The forecast for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) in 2026 suggests a price of $0.17, representing a 36.30% move from today’s price.
Average Target: $0.17
Market Outlook: bullish based on current trend indicators.
Key Drivers in 2026:- Earnings growth projections.
- Competitive performance in the Healthcare.
- Macroeconomic factors such as interest rates and inflation.
Shenzhen Neptunus Interlong Bio-technique Company Limited Stock Forecast 2030
By 2030, Meyka AI projects 8329.HK could trade near $0.19, showing a potential 57.13% compared to current levels.
Average Target: $0.19
Market Outlook: bullish.
What could influence the 2030 forecast:- Technological innovation and product cycles.
- Expansion into global markets.
- Long-term investor sentiment toward Shenzhen Neptunus Interlong Bio-technique Company Limited.
Shenzhen Neptunus Interlong Bio-technique Company Limited 7-Year Stock Forecast (2032–2033)
Looking 7 years ahead, the long-term forecast for 8329.HK points to a price around $0.21, which is a projected 68.59% move from today’s level.
Average Target: $0.21
Outlook: bullish, depending on macroeconomic conditions and sector growth.
Long-Term Drivers:- Global economic expansion or contraction.
- Regulatory and policy environment.
- Shenzhen Neptunus Interlong Bio-technique Company Limited’s ability to maintain market leadership.